Expression and characterization of Syrian golden hamster p16, a homologue of human tumor suppressor p16INK4A

Biochemical and Biophysical Research Communications

Volumn 304, Issue 2, 2003, Pages 241-247

  Li, Junan ^a   Qin, Dongyan ^b   Knobloch, Thomas J ^b   Tsai, Ming Daw ^b,c   Weghorst, Christopher M ^b,c   Scott Melvin, W ^a,c   Muscarella, Peter ^a,c  

^a THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b OHIO STATE UNIVERSITY   (United States)

^c OHIO STATE UNIVERSITY   (United States)

Author keywords

Functional characterization; P16INK4A; Structural modeling; Syrian golden hamster

Indexed keywords

COMPLEMENTARY DNA; CYCLIN DEPENDENT KINASE 4; PROTEIN P16;

ANIMAL CELL; ARTICLE; BIBLIOGRAPHIC DATABASE; CARCINOGENESIS; CONTROLLED STUDY; DRUG ANALYSIS; ENZYME ACTIVITY; ENZYME BINDING; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; NONHUMAN; NUCLEOTIDE SEQUENCE; PANCREAS CARCINOMA; PRIORITY JOURNAL; PROTEIN STABILITY; SEQUENCE HOMOLOGY; SYRIAN HAMSTER; TUMOR SUPPRESSOR GENE;

CRICETINAE; MESOCRICETUS AURATUS;

EID: 0344088436     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-291X(03)00577-1     Document Type: Article

References (30)

1. Ortega S., Malumbres M., Barbacid M. Cyclin D-dependent kinases, INK4 inhibitors and cancer. Biochim. Biophys. Acta. 1602:2002;73-87.
2. Li J., Byeon I.-J., Poi M., Ericson K., Selby T., O'Maille P., Qin D., Tsai M.-D. The structure-function relationship of p16 tumor suppressor. Melanie Ehrlich DNA Alterations in Cancer: Genetic and Epigenetic Changes. 2002;71-83 BioTechniques Books, Eaton Publishing, MA.
3. Schutte M., Hruban R.H., Geradts J., Maynard R., Hilgers W., Rabindran S.K., Moskaluk C.A., Hahn S.A., Schwarte-Waldhoff I., Schmiegel W., Baylin S.B., Kern S.E., Herman J.G. Abrogation of the Rb/p16 tumor-suppressive pathway in virtually all pancreatic carcinomas. Cancer Res. 57:1997;3126-3130.
4. Naumann M., Savitskaia N., Eilert C., Schramm A., Kalthoff H., Schmiegel W. Frequent codeletion of p16/MTS1 and p15/MTS2 and genetic alterations in p16/MTS1 in pancreatic tumors. Gastroenterology. 110:1996;1215-1224.
5. Hu Y.X., Watanabe H., Ohtsubo K., Yamaguchi Y., Ha A., Okai T., Sawabu N. Frequent loss of p16 expression and its correlation with clinicopathological parameters in pancreatic carcinoma. Clin. Cancer Res. 3:1997;1473-1477.
6. INK4 mutations N. Engl. J. Med. 333:1995;970-974.
7. Kobayashi S., Shirasawa H., Sashiyami H., Kawahira H., Kaneko K., Asano T., Ochiai T. p16INK4a expression adenovirus vector to suppress pancreatic cancer cell proliferation. Clin. Cancer Res. 5:1999;4182-4185.
8. American Cancer Society, 2003. Cancer Facts and Figures-2003, American Cancer Society, New York, pp. 12-24.
9. Jemal A., Murray T., Samuels A., Ghafoor A., Ward E., Thun M.J. Cancer statistics 2003. CA Cancer J. Clin. 53:2003;5-26.
10. Pancreatic Cancer: An Agenda for Action. Report of the Pancreatic Cancer Progress Review Group. NIH Publication Number 01-4940, National Cancer Institute, 2001.
11. Pour P.M., Runge R.G., Birt D., Gingell R., Lawson T., Nagel D., Wallcave L., Salmasi S.Z. Current knowledge of pancreatic carcinogenesis in the hamster and its relevance to the human disease. Cancer. 47:1981;1573-1587.
12. Chang K.W., Laconi S., Mangold K.A., Hubchak S., Scarpelli D.G. Multiple genetic alterations in hamster pancreatic ductal adenocarcinomas. Cancer Res. 55:1995;2560-2568.
13. Cerny W.L., Mangold K.A., Scarpelli D.G. K-ras mutation is an early event in pancreatic duct carcinogenesis in the Syrian golden hamster. Cancer Res. 52:1992;4507-4513.
14. Husain Z., Fei Y.B., Roy S., Solt D.B., Polverini P.J., Biswas D.K. Sequential expression and cooperative interaction of c-Ha-ras and c-erbB genes in vivo chemical carcinogenesis. Proc. Natl. Acad. Sci. USA. 86:1989;1264-1268.
15. Wong D.T. Amplification of the c-erb B1 oncogene in chemically induced oral caricinomas. Carcinogenesis. 8:1987;1963-1965.
16. Sumida T., Hamakawa H., Sogawa K., Bao Y., Zen H., Sugita A., Nezu K., Abe Y., Tanioka H., Ueda N. Telomerase activation and cell proliferation during 7,12-dimethylbenz[a]anthracebe-induced hamster cheek pouch carcinogenesis. Mol. Carcinog. 25:1999;164-168.
17. Chang K.W., Sarraj S., Lin S.C., Tsai P.I., Solt D. p53 expression, p53 and Ha-ras mutation and telomerase activation during nitrosamine-mediated hamster pouch carcinogenesis. Carcinogenesis. 21:2000;1441-1451.
18. Muscarella P., Li J., Tsutsumi M., Knobloch T.J., Casto B.C., Melvin W.S., Weghorst C.M. Deletional inactivation of the p16/MTS1 tumor suppressor gene in hamster pancreatic tumors: analysis by multiplex real-time PCR. J. Gastrointest. Surg. 7:2003;293.
19. INK4b cDNAs and their homozygous gene deletion in cheek pouch and pancreatic tumor cells Gene. 278:2001;235-243.
20. INK4A: determination of solution structure and analyses of its interaction with cyclin-dependent kinase 4 Mol. Cell. 1:1998;421-431.
21. INK4A Biochemistry. 38:1999;2928-2940.
22. Koh J., Enders G.H., Dynlacht B.D., Harlow E. Tumor-derived p16 alleles encoding proteins defective in cell-cycle inhibition. Nature. 375:1995;506-510.
23. Li J., Tsai M.-D. Novel insights into the INK4-CDK4/6-Rb pathway: counter action of gankyrin against INK4 proteins regulates the CDK4-mediated phosphorylation of Rb. Biochemistry. 41:2002;3977-3983.
24. INK4C J. Mol. Biol. 294:1999;201-211.
25. Pace C.N. Determination and analysis of urea and guanidinium hydrochloride denaturation curves. Methods Enzymol. 131:1986;266-280.
26. Lycan D.E., Stafford K.A., Bollinger W., Breeden L.L. A new Saccharomyces cerevisiae ankyrin repeat-encoding gene required for a normal rate of cell proliferation. Gene. 171:1996;33-40.
27. INK4A: structural characterization of wild-type and mutant proteins by NMR and circular dichroism Biochemistry. 35:1996;9475-9487.
28. Guex N., Peitsch M.C. SWISS-MODEL and the Swiss-pdb viewer: an environment for comparative protein modeling. Electrophoresis. 18:1997;2714-2723.
29. Brotherton D.H., Dganaraj V., Wick S., Brizula L., Domaille P.J., Volyanik E., Xu X., Parisin E., Smith B.O., Archer S.J., Serrano M., Brenner S.L., Blundell T.L., Laue E.D. Crystal structure of the complex of the cyclin D-dependent kinase Cdk6 bound to the cell-cycle inhibitor p19INK4d. Nature. 395:1998;244-250.
30. Russo A.A., Tong L., Lee J., Jeffery P.D., Pavletich N.P. Structural basis for inhibition of the cyclin-dependent kinase Cdk6 by the tumor suppressor p16Ink4a. Nature. 395:1998;237-243.